-
The World's First Genetically Modified Spider Could Change The Future Of Military Tech
Tuesday, May 27, 2025 - 5:58am | 424Read More...Scientists backed by the U.S. Navy have created the world's first genetically modified spider. This achievement could pave the way to a new category of high-performance materials with major implications for defense, aerospace, and medicine. What Happened: A team at the University of Bayreuth in...
-
Bill Gates Gets Excited About Future Of Tech That Has 'Revolutionized Health' Over Past Decade
Monday, February 6, 2023 - 11:17pm | 522Read More...Microsoft co-founder Bill Gates said on Twitter that the gene-editing technology, CRISPR or clustered regularly interspaced short palindromic repeats, has “revolutionized health over the past decade.” What Happened: Gates said Monday that he was “excited to see” how CRISPR...
-
Could A Hypoallergenic Cat Be Coming Soon?
Tuesday, March 29, 2022 - 5:14pm | 466Read More...If science has its way, your cat allergy won't be an excuse to skip Thanksgiving at your grandmother's house, where her five cats also reside. Hypoallergenic cats could be making a debut sooner rather than later due to the magic of CRISPR gene-editing technology. While fur and dander, in...
-
Qiagen Launches CRISPR-Specific Products For Gene-Editing Experiments
Tuesday, June 22, 2021 - 6:45am | 154Read More...Qiagen NV (NYSE: QGEN) has launched dedicated solutions specific to CRISPR technology used for editing genomes and modifying gene function. QiaPrep&Amp CRISPR Kit and Q-Primer Solutions expand Qiagen portfolio for CRISPR applications. The solutions allow researchers to analyze...
-
AbbVie, Caribou Biosciences Ink Licensing Agreement For (CAR)-T Cell Therapeutics
Wednesday, February 10, 2021 - 11:04am | 245Read More...AbbVie Inc (NYSE: ABBV) and Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen receptor (CAR)-T cell therapeutics. AbbVie will utilize Caribou's Cas12a CRISPR hybrid RNA-DNA genome editing and cell...
-
IPO Outlook: Do 4 Biotechs Mean Maybe The IPO Market Is Back?
Tuesday, May 3, 2016 - 12:10pm | 463Read More...2016’s slow start for Initial Public Offerings (IPO) could be over, as four biotechs follow in the wake of several successful IPOs, most notably, BATS Global Markets, Inc. (BATS: BATS) and American Renal Associates Holdings Inc (NYSE: ARA). These stocks are up 25 and 26 percent, respectively...






